Patent application number | Description | Published |
20090203123 | Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per SE, and uses thereof - The invention relates to newly identified cancer associated antigens. It has been discovered that each of these molecules provokes antibodies when expressed by a subject. The ramifications of this observation are also a part of this invention. | 08-13-2009 |
20100330075 | MONOCLONAL HUMAN TUMOR-SPECIFIC ANTIBODY - Provided are novel human tumor-specific antibodies as well as fragments, derivatives and variants thereof that recognize tumor-associated antigen NY-ESO-1. In addition, pharmaceutical compositions comprising such antibodies and mimics thereof in the treatment of tumors are described. | 12-30-2010 |
20110123447 | METHOD OF PROVIDING HUMAN TUMOR-SPECIFIC ANTIBODIES - Provided are novel tumor-specific binding molecules, particularly human antibodies as well as fragments, derivatives and variants thereof that recognize tumor-associated antigens and that are obtained from a tumor patient who shows at least partial clinical response or is symptom-free. In addition, pharmaceutical compositions comprising such binding molecules, antibodies and mimics thereof and methods of screening for novel binding molecules, which may or may not be antibodies as well as targets in the treatment of tumors are described. | 05-26-2011 |
20110123637 | PROTAMINE/RNA NANOPARTICLES FOR IMMUNOSTIMULATION - The present invention relates to protamine/RNA nanoparticles of defined average size, a pharmaceutical composition containing said nanoparticles and to a method of producing the same. The nanoparticles of the present invention is particularly useful as an immunostimulating medicament with a precise pattern of immunostimulation different from the prior art. | 05-26-2011 |
20130295091 | COMBINATION THERAPY INCLUDING TUMOR ASSOCIATED ANTIGEN BINDING ANTIBODIES - The present invention relates to a combination therapy including tumor associated antigen binding antibodies. | 11-07-2013 |
20140186363 | MAGEA3 BINDING ANTIBODIES - The present invention relates to MAGEA3 binding antibodies. | 07-03-2014 |